Navigation Links
Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
Date:11/10/2008

umor agent that contains an aza-anthracenedione molecular structure, differentiating it from anthracycline chemotherapy agents, was discovered by our scientists in Bresso, Italy. Pixantrone is a novel DNA major groove binder that contains an aza-anthracenedione molecular structure, differentiating it from anthracycline chemotherapy agents. Anthracyclines have been shown to be very active clinically in a number of tumor types, such as lymphoma, leukemia, and breast cancer. For these diseases, anthracycline-containing chemotherapy regimens are effective in first-line (initial) treatment. However, they may cause cumulative heart damage that limits lifetime dosage and does not allow for retreatment. Pixantrone has been designed to reduce the potential for heart damage compared to currently available anthracyclines or anthracenediones without a loss in anti-tumor or immunomodulatory activities.

About Non-Hodgkin's Lymphoma

Non-Hodgkin's lymphoma (NHL) is caused by the abnormal proliferation of white blood cells and normally spreads through the lymphatic system, a system of vessels that drains fluid from the body. NHL can be broadly classified into two main forms -- aggressive NHL, a rapidly spreading acute form of the disease, and indolent NHL, which progresses more slowly. According to the National Cancer Institute's SEER database there were nearly 400,000 people in the U.S. with NHL in 2004. The American Cancer Society estimates that in the United States 66,120 people are expected to be diagnosed with NHL in 2008. Additionally, approximately 19,160 are expected to die from this disease in 2008.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit http://www.celltherapeutics.com.

This press re
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
2. InteRNA Technologies and VU University Medical Center to Develop microRNA-Based Diagnostics and Therapeutics for Cancer
3. Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
4. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
5. Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
6. In Vivo Data on Taligen Therapeutics Pipeline Candidates Presented at the XXII International Complement Workshop
7. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
8. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
9. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
10. PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy
11. Data from In Vivo Disease Models on Taligen Therapeutics Pipeline Candidates to be Presented at the XXII International Complement Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... YORK and VIENNA , July ... at a press conference in New York ... PD01A, a vaccine against Parkinson,s disease. PD01A is the first ... to enter clinical testing. The Michael J. Fox ... $ 1.5 million grant, and presented at the press conference ...
(Date:7/31/2014)... AUSTIN, Texas , July 31, 2014 Vermillion, ... cancers and women,s health, will hold a conference call on ... discuss results for the second quarter ended June 30, 2014. ... to the call. Vermillion,s Chairman, President and CEO ... a question and answer period. Date: Thursday, August ...
(Date:7/31/2014)... July 31, 2014 The Galien Foundation today ... Galien USA Awards. The Prix ... and recognizes the technical, scientific and clinical research skills ... This year brings the highest number of nominees since ... . Nominees include biomedical products across three categories ...
Breaking Medicine Technology:First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5
... HEIGHTS, Ill., Nov. 1, 2011 When it comes to ... and determine the best course of treatment depends on the ... Palos Community Hospital offers patients the most advanced technology in ... is one of only two PEM scanners in the Chicagoland ...
... 1, 2011 Custom Spine unveils its new auxiliary connector ... an extension to the company,s ISSYS LP pedicle screw system, ... screw to be fully seated while maintaining full polyaxial motion ... is unique in its ability to accept multiple rod sizes ...
Cached Medicine Technology:Palos Offers New Technology in the Fight Against Breast Cancer 2Custom Spine Features Unique Auxiliary Connector System at NASS 2
(Date:7/31/2014)... been rising steadily in the U.S in recent years. ... Health, the number of individuals reporting past year heroin ... Emerging evidence suggests the increase may be linked to ... intranasal PO use to heroin use, with POs providing ... injection. This drug-use trajectory appears to have become ...
(Date:7/31/2014)... Ticket Down is a reliable source for ... Park in suburban Denver on Tuesday, September 9th. Over ... found a second home competing on American soil. They have ... friendly games and will look to have another successful experience ... Commerce City, Colorado. The match will be Mexico’s second of ...
(Date:7/31/2014)... developed a novel method for creating self-assembled protein/polymer ... living cells. The work offers a promising new ... tissue engineering applications. The findings were published in ... International Edition . , "We have demonstrated that, ... can form completely new types of aggregates. These ...
(Date:7/31/2014)... News) -- Preschoolers with special needs benefit from going ... according to a new study. Classmates with ... disabilities, researchers found. On the other hand, development of ... language skills, they said. "We were surprised to ... the end of the school year when considering those ...
(Date:7/31/2014)... Atlanta-based Jvion, a leader in clinical predictive algorithms ... predictive population health analytics as part of an ongoing ... healthcare. Ritesh Sharma, Jvion COO, commented, “it is critical ... the impact of and potential within predictive analytics. There ... good portion of it is conflicting or confusing. The ...
Breaking Medicine News(10 mins):Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 3Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 3Health News:Carnegie Mellon chemists create nanofibers using unprecedented new method 2Health News:Preschoolers With Special Needs May Gain From 'Inclusion' Classrooms 2Health News:Jvion Releases Top Three Lessons in Predictive Population Health Analytics 2Health News:Jvion Releases Top Three Lessons in Predictive Population Health Analytics 3
... Health Services Bring Better Quality of Care and ... April 15 Vocollect Healthcare Systems, Inc. and ... and management company for the long-term care, senior ... an agreement whereby Pathway Health Services will become ...
... Baptist ... the employee phase of the "Our House is Your House" ... Wilson Family Center for Good Grief as they have surpassed ... November of 2008, with 60 employee volunteers across the system ...
... been aroused in the identification and isolation of liver ... bone marrow cells have been found to have the ... immunological methods is difficult because of the complicated surface ... successful passage has been published., A research article to ...
... patients pick the tunes, study suggests , , WEDNESDAY, April 15 ... want to plug in that iPod or pop in a ... disease reduced their heart rates, breathing rate and blood pressure ... 23 previous studies found. , The report, published in the ...
... Delcath Systems, Inc. (Nasdaq: DCTH ) will ... Eastern Time on Wednesday, April 22, 2009. Richard Taney, ... host the call.(Logo: http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO ... may dial (888) 790-3326 (U.S./Canada) and use Conference Password: ...
... 15 Based on its recent analysis of ... tomography (CT) markets market, Frost & Sullivan recognizes ... Frost & Sullivan Award for Enabling Technology. Zecotek,s ... and solid-state photo detector technologies that will help ...
Cached Medicine News:Health News:Pathway Health Services and Vocollect Healthcare Systems Announce Strategic Partnership 2Health News:Baptist Colleagues Raise $1 Million for Baptist Trinity Hospice House and Kemmons Wilson Family Center for Good Grief 2Health News:Soothing Songs Please the Heart 2Health News:Delcath Systems to Host Quarterly Update Conference Call 2Health News:Frost & Sullivan Recognizes Zecotek Photonic's Medical Imaging Achievement, Development of Next-Generation Scintillation Crystals and Photo Detector Technology 2Health News:Frost & Sullivan Recognizes Zecotek Photonic's Medical Imaging Achievement, Development of Next-Generation Scintillation Crystals and Photo Detector Technology 3Health News:Frost & Sullivan Recognizes Zecotek Photonic's Medical Imaging Achievement, Development of Next-Generation Scintillation Crystals and Photo Detector Technology 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: